ChartRow logo
Data provided bySource: Twelve Data
GH
$143.28-0.52%
as of close, Nov 17, 2026
☾ AH $143.28 -0.52%
Share this page

GH financial statements

The full income statement, balance sheet, and cash-flow statement for Guardant Health Inc. (GH), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Financial overview#

Revenue

5Y CAGR +27.9%5Y CAGR +27.9%YoY +36.1%
$1.3B TTM$361M Q3 '26
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Gross profit

YoY +37.6%
$833.7M TTM$236.2M Q3 '26
FY23FY24FY25TTM
Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Operating income

5Y n/m5Y n/mYoY n/m
−$504M TTM−$132.8M Q3 '26
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Net income

5Y n/m5Y n/mYoY n/m
−$485.1M TTM−$124.4M Q3 '26
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

EPS (diluted)

5Y n/m5Y n/mYoY n/m
−$3.68 TTM−$0.93 Q3 '26
FY19FY20FY21FY22FY23FY24FY25TTM
Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Operating cash flow

5Y n/m5Y n/mYoY n/m
−$173.5M TTM−$23.7M Q3 '26
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Capital expenditure

5Y CAGR +6.0%5Y CAGR +6.0%YoY +30.2%
$58.7M TTM$13.5M Q3 '26
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Free cash flow

5Y n/m5Y n/mYoY n/m
−$232.1M TTM−$37.2M Q3 '26
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Shares (diluted)

5Y +28.6%5Y +28.6%YoY +7.7%
131.8M TTM134.4M Q3 '26
FY19FY20FY21FY22FY23FY24FY25TTM
Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Every GH chart on Trends →

Shares outstanding (point-in-time)

2024-09 123.6M2024-12 123.4M2025-03 123.9M2025-06 124.7M2025-09 126.0M2025-12 131.2M2026-03 132.6M2026-06 134.2M2026-09 135.3M+9.5% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

PeriodRangeOrderChangeFiguresAs-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue982M+32.9%739M+31.0%564M+25.5%450M+20.3%374M+30.3%
633M+40.9%449M+33.3%337M——
Cost of revenue349M+20.4%290M+27.6%227M——
Research & development364M+4.7%348M-5.3%367M-1.8%374M+42.0%263M+75.6%
Selling, general & administrative706M+29.5%545M+20.8%451M-2.8%464M+16.4%399M+33.2%
General & administrative211M+17.4%180M+15.6%156M-5.0%164M-20.7%207M+7.2%
Selling & marketing495M+35.5%365M+23.6%295M-1.5%300M+56.3%192M+80.1%
Amortization of intangibles1.70M-22.7%2.20M-18.5%2.70M+8.0%2.50M+31.6%1.90M+5.6%
Operating income-437M+1.4%-444M+21.4%-565M-3.7%-544M-32.5%-411M-61.2%
Interest expense3.90M+51.0%2.58M+0.1%2.58M+0.0%2.58M+0.0%2.58M-45.9%
Interest & investment income34.1M-36.5%53.7M+51.8%35.4M+482.7%6.07M+54.4%3.93M-61.4%
Other non-operating income-10.5M+75.4%-42.6M-180.1%53.2M+516.1%-12.8M-150.8%25.2M+591.5%
Gain (loss) on equity securities0.00+100.0%-44.4M-155.7%79.7M+1122.8%-7.79M0.00
Pre-tax income-418M+4.0%-435M+9.1%-479M+26.7%-653M-70.0%-384M-56.3%
Income tax-1.26M-198.4%1.28M+87.4%685K-39.9%1.14M+279.7%300K-20.8%
-416M+4.6%-436M+9.0%-479M+26.8%-655M-61.4%-406M-59.8%
Net income to non-controlling interest——0.000.00-100.0%20.9M+178.7%
Net income to common-416M+4.6%-436M+9.0%-479M+26.8%-655M-61.4%-406M-59.8%
-$3.32+6.7%-$3.56+16.8%-$4.28+33.2%-$6.41-60.3%-$4.00-53.8%
EPS (basic)-$3.32+6.7%-$3.56+16.8%-$4.28+33.2%-$6.41-60.3%-$4.00-53.8%
Weighted-avg shares (basic)125M+2.1%123M+9.6%112M+9.6%102M+0.9%101M+3.9%
Weighted-avg shares (diluted)125M+2.1%123M+9.6%112M+9.6%102M+0.9%101M+3.9%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
1.47B+38.9%1.06B-21.7%1.35B+13.1%1.19B+7.0%1.11B-41.0%
Cash & equivalents378M-28.0%526M-53.6%1.13B+700.3%142M-71.2%492M-40.9%
Short-term investments———870M+97.4%441M-54.2%
Accounts receivable138M+25.0%110M+24.2%88.8M-8.7%97.3M-0.4%97.7M+83.2%
Inventory85.9M+20.8%71.1M+14.7%61.9M+20.1%51.6M+68.2%30.7M+35.0%
Prepaid expenses40.7M+20.5%33.8M+21.8%27.7M-12.0%31.5M-40.6%53.1M+203.7%
2.01B+35.5%1.49B-16.8%1.79B+11.0%1.61B-27.0%2.20B-3.0%
Property, plant & equipment146M+6.7%137M-5.7%145M-13.6%168M+34.9%124M+98.2%
Operating lease right-of-use159M+11.7%142M-9.7%158M-9.4%174M-8.2%189M+407.3%
Goodwill77.3M+2248.2%3.29M+0.0%3.29M+0.0%3.29M+0.0%3.29M+0.0%
Intangible assets25.9M+283.4%6.76M-24.7%8.98M-23.4%11.7M-17.5%14.2M-12.1%
Long-term investments———0.00-100.0%698M+183.1%
Other non-current assets28.5M-23.4%37.2M-70.1%124M+102.1%61.5M+0.8%60.9M+253.2%
303M+34.2%226M+9.6%206M+6.6%193M-0.8%195M+191.4%
Accounts payable54.4M+41.2%38.6M-25.5%51.7M-24.9%68.9M+292.0%17.6M+139.5%
Accrued liabilities77.9M+14.0%68.3M+7.7%63.5M-63.9%176M+66.9%105M+365.4%
Deferred revenue50.8M+43.1%35.5M+97.4%18.0M+3.2%17.4M+53.7%11.3M+32.5%
Current lease liability27.7M-5.3%29.2M+4.5%27.9M+27.8%21.9M+70.2%12.9M+93.8%
2.11B+30.0%1.63B-0.2%1.63B+5.0%1.55B-0.6%1.56B+70.2%
Long-term debt1.50B+31.6%1.14B+0.2%1.14B+0.2%1.14B+0.2%1.13B+40.7%
Deferred revenue (non-current)9.00M+47.5%6.10M+22.0%5.00M+31.6%3.80M—
Non-current lease liability178M+8.6%164M-11.6%186M-11.5%210M-7.1%226M+443.9%
Operating lease liability (total)206M+6.5%194M-9.5%214M-7.8%232M-2.9%239M+395.7%
Other non-current liabilities128M+37.6%92.8M-3.3%96.0M+945.9%9.18M+133.4%3.93M+158.8%
-99.3M+28.9%-140M-188.0%159M+163.7%60.2M-90.7%645M-50.3%
Additional paid-in capital2.90B+18.7%2.44B+6.1%2.30B+32.3%1.74B+5.1%1.66B-12.9%
Retained earnings-2.99B-16.1%-2.58B-20.4%-2.14B-28.8%-1.66B-65.0%-1.01B-66.1%
Treasury stock
—0.00———
Accumulated other comprehensive income-4.85M+6.7%-5.20M-41.5%-3.67M+81.2%-19.5M-309.8%-4.76M-276.6%
Total equity incl. non-controlling-99.3M+28.9%-140M-188.0%159M+163.7%60.2M-90.7%645M
Total liabilities & equity2.01B+35.5%1.49B-16.8%1.79B+11.0%1.61B-27.0%2.20B-3.0%
Common shares issued131M+5.4%124M+1.9%122M+18.5%103M+0.8%102M+1.6%
Common shares outstanding131M+5.4%124M+1.9%122M+18.5%103M+0.8%102M+1.6%
Shares outstanding (cover)131M+6.3%123M+1.4%122M+18.6%103M+0.8%102M+1.4%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
-185M+23.0%-240M+26.2%-325M-5.0%-309M-48.1%-209M-101.1%
Depreciation & amortization39.7M-6.3%42.4M-1.2%42.9M+19.2%36.0M+61.5%22.3M+38.6%
Intangible amortization1.70M-22.7%2.20M-18.5%2.70M+8.0%2.50M+31.6%1.90M+5.6%
Share-based compensation166M+18.4%140M+54.7%90.8M-4.1%94.7M-37.5%151M+5.1%
Deferred income taxes-1.71M-694.1%287K+153.0%-541K-129.2%-236K-232.6%178K+34.8%
Change in receivables28.2M+31.7%21.4M+355.3%-8.38M-2134.1%-375K-100.8%44.4M+711.9%
Change in inventory14.8M+61.9%9.13M-11.7%10.3M-50.5%20.9M+163.0%7.96M+5.6%
Change in payables
————8.64M+209.9%
-627M-140.0%-261M-131.1%840M+460.9%150M+337.2%-63.2M+89.8%
Capital expenditure48.3M+37.7%35.1M+71.3%20.5M-73.6%77.5M+3.2%75.0M+107.4%
Free cash flow-233M+15.2%-275M+20.4%-345M+10.7%-387M-36.2%-284M-102.7%
Acquisitions59.0M0.000.00—0.00
Sales/maturities of investments307M+778.1%35.0M-97.7%1.49B+169.3%555M-41.7%952M
Other investing activities——-1.53M0.000.00
671M+67482.8%-996K-100.2%477M+352.5%-189M-183.0%-66.8M-104.7%
Long-term debt issued0.000.000.000.000.00
Long-term debt repaid0.000.000.000.000.00
Common stock issued257M0.00-100.0%493M0.000.00-100.0%
Common stock repurchased45.0M0.000.000.000.00
Dividends paid0.000.000.000.000.00
Other financing activities3.60M+2450.3%-153K-102.5%6.03M+630.6%-1.14M-22.2%-930K
Net change in cash-140M+72.2%-504M-150.8%992M+383.1%-350M-2.8%-341M-149.4%
Interest paid3.77M0.000.00—0.00
Income taxes paid869K-13.7%1.01M-48.9%1.97M+47.9%1.33M+238.7%393K+18.7%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap13.3B+252.2%3.79B+18.7%3.19B+14.6%2.79B-72.6%10.2B-21.2%
P/S13.6×+165.1%5.1×-14.0%6.0×-7.9%6.5×-76.3%27.2×-39.5%
P/B——14.0×-16.3%16.7×+5.9%15.8×+58.7%
Source filing10-K10-K10-K10-K10-K
Fiscal yearCEOTotal, as reportedActually paidOther executives, average$100 in the stock$100 in peers
FY2025Helmy Eltoukhy $8.7M / $79.8MAmirAli Talasaz $8.7M / $79.8M$17.3M$159.6M$3.4M$79.25$124.75
FY2024Helmy Eltoukhy $11.6M / $15MAmirAli Talasaz $11.6M / $15M$23.2M$30.1M$4M$23.70$93.49
FY2023Helmy Eltoukhy $11.6K / −$4.2MAmirAli Talasaz $26.4K / −$4.2M$38K−$8.4M$4.3M$20.99$94.03
FY2021Helmy Eltoukhy $13.7K / −$31MAmirAli Talasaz $13.3K / −$31M$26.9K−$62M$5M$77.61$100.02
FY2020Helmy Eltoukhy$113.9M$196.4M$29.8M——

From the pay-versus-performance table of each proxy statement (DEF 14A), the newest that states the year. “Actually paid” values stock awards at the year’s closing price, so it falls when the stock does. A year two chief executives shared lists each one’s pay, as reported / actually paid, and the totals are both. $100 in the stock and in the peer group the proxy names are the newest proxy’s, from the start of its first year.

About this data

Source: GH’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all GH filings on SEC EDGAR → Not investment advice.